FDA Requiring Labeling Changes to Benzodiazepine Prescribing Information

THURSDAY, Sept. 24, 2020 -- In response to reports of misuse and abuse of benzodiazepines, the U.S. Food and Drug Administration is now requiring class-wide labeling changes to the prescribing information, the agency announced yesterday. The Boxed...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news